SHANGHAI – BGI, a powerhouse gene sequencing organization based in China, and the Vancouver Prostate Centre agreed to formalize their relationship by establishing a joint translational cancer research laboratory in Vancouver, British Columbia. They will use genome research to develop new biomarkers and cancer therapies, initially focusing on drug-resistant forms of bladder, kidney and prostate cancers.